HK1177454A1 - 5-amino- 4-hydroxypentoyl amides 5--4-- - Google Patents

5-amino- 4-hydroxypentoyl amides 5--4--

Info

Publication number
HK1177454A1
HK1177454A1 HK13104373.4A HK13104373A HK1177454A1 HK 1177454 A1 HK1177454 A1 HK 1177454A1 HK 13104373 A HK13104373 A HK 13104373A HK 1177454 A1 HK1177454 A1 HK 1177454A1
Authority
HK
Hong Kong
Prior art keywords
hydroxypentoyl
amides
amino
hydroxypentoyl amides
Prior art date
Application number
HK13104373.4A
Other languages
English (en)
Chinese (zh)
Inventor
Genadiy Kalayanov
Bart Rudolf Romanie Kesteleyn
Kevin Parkes
Bengt Bertil Samuelsson
Wim Bert Griet Schepens
Johannes Wilhelmus J Thuring
Hans Kristian Wallberg
Jrg Kurt Wegner
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of HK1177454A1 publication Critical patent/HK1177454A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK13104373.4A 2009-12-11 2013-04-10 5-amino- 4-hydroxypentoyl amides 5--4-- HK1177454A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09178979 2009-12-11
EP10162370 2010-05-10
PCT/EP2010/069328 WO2011070131A1 (en) 2009-12-11 2010-12-10 5-amino- 4-hydroxypentoyl amides

Publications (1)

Publication Number Publication Date
HK1177454A1 true HK1177454A1 (en) 2013-08-23

Family

ID=43534084

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13104373.4A HK1177454A1 (en) 2009-12-11 2013-04-10 5-amino- 4-hydroxypentoyl amides 5--4--

Country Status (24)

Country Link
US (1) US8592429B2 (ru)
EP (1) EP2509950B1 (ru)
JP (1) JP5797662B2 (ru)
KR (1) KR101771698B1 (ru)
CN (1) CN102770413B (ru)
AP (1) AP3217A (ru)
AR (1) AR079354A1 (ru)
AU (1) AU2010329867B2 (ru)
BR (1) BR112012013493B1 (ru)
CA (1) CA2783929C (ru)
DK (1) DK2509950T3 (ru)
EA (1) EA020758B1 (ru)
ES (1) ES2536774T3 (ru)
HK (1) HK1177454A1 (ru)
IL (1) IL219272A (ru)
JO (1) JO3090B1 (ru)
MX (1) MX2012006613A (ru)
NZ (1) NZ599916A (ru)
PL (1) PL2509950T3 (ru)
PT (1) PT2509950E (ru)
SG (1) SG181609A1 (ru)
TW (1) TWI485149B (ru)
UY (1) UY33098A (ru)
WO (1) WO2011070131A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3575301A4 (en) 2017-03-16 2020-08-05 Jiangsu Hengrui Medicine Co., Ltd. HETEROARYL [4,3-C] PYRIMIDINE-5-AMINE DERIVATIVE, PROCESS FOR PREPARATION AND MEDICAL USES

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
EP0534511A1 (en) * 1991-08-16 1993-03-31 Merck & Co. Inc. HIV protease inhibitors useful for the treatment of aids
CN1089269A (zh) * 1993-01-04 1994-07-13 希巴-盖吉股份公司 新颖的作为治疗剂的5-氨基-4-羟基己酸衍生物
US5733882A (en) * 1994-01-17 1998-03-31 Smithkline Beecham Corporation Retroviral protease inhibitors
EP0708085B1 (en) * 1994-10-19 2002-07-17 Novartis AG Antiviral ethers of aspartate protease substrate isosteres
ATE343567T1 (de) * 2001-02-14 2006-11-15 Tibotec Pharm Ltd Breitspektrum 2-(substituierte-amino)- benzothiazol-sulfonamide hiv protease inhibitoren
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
US7834043B2 (en) * 2003-12-11 2010-11-16 Abbott Laboratories HIV protease inhibiting compounds
DE602006006418D1 (de) * 2005-02-10 2009-06-04 Medivir Ab Hiv-protease-inhibitoren
CN101115713A (zh) * 2005-02-10 2008-01-30 美迪维尔公司 人类免疫缺陷性病毒蛋白酶抑制剂
WO2007048557A1 (en) * 2005-10-25 2007-05-03 Medivir Ab Protease inhibitors
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2008011117A2 (en) * 2006-07-21 2008-01-24 Gilead Sciences, Inc. Antiviral protease inhibitors

Also Published As

Publication number Publication date
MX2012006613A (es) 2012-07-10
IL219272A (en) 2014-09-30
EP2509950A1 (en) 2012-10-17
EP2509950B1 (en) 2015-02-25
BR112012013493A2 (pt) 2016-05-31
PL2509950T3 (pl) 2015-10-30
WO2011070131A1 (en) 2011-06-16
TWI485149B (zh) 2015-05-21
BR112012013493A8 (pt) 2017-12-26
AR079354A1 (es) 2012-01-18
CN102770413B (zh) 2015-08-26
JP5797662B2 (ja) 2015-10-21
BR112012013493B1 (pt) 2020-12-08
KR101771698B1 (ko) 2017-08-25
UY33098A (es) 2011-06-30
CN102770413A (zh) 2012-11-07
DK2509950T3 (en) 2015-05-18
EA201290487A1 (ru) 2012-11-30
EA020758B1 (ru) 2015-01-30
KR20120107104A (ko) 2012-09-28
CA2783929A1 (en) 2011-06-16
SG181609A1 (en) 2012-07-30
JO3090B1 (ar) 2017-03-15
IL219272A0 (en) 2012-06-28
AP2012006228A0 (en) 2012-04-30
US8592429B2 (en) 2013-11-26
AP3217A (en) 2015-04-30
US20120295920A1 (en) 2012-11-22
JP2013513576A (ja) 2013-04-22
CA2783929C (en) 2020-04-07
ES2536774T3 (es) 2015-05-28
AU2010329867A1 (en) 2012-05-24
TW201130823A (en) 2011-09-16
PT2509950E (pt) 2015-06-08
NZ599916A (en) 2013-10-25
AU2010329867B2 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
DK3023438T3 (en) Anti-gitr-antistoffer
DK2457337T3 (en) Specialtilpasset impuls-burst
EP2457176A4 (en) VIRTUAL-MACHINE-BASED APPLICATION-SERVICE PROVISION
EP2462514A4 (en) GREEN BOOKS
EP2515891A4 (en) 3-keto-N-propargyl-1-aminoindan
EP2519921A4 (en) CALL TRACING
DK2464943T3 (en) Systemintegration
GB0900568D0 (en) Poymerisation
GB0900319D0 (en) Hydrocharger
HK1177454A1 (en) 5-amino- 4-hydroxypentoyl amides 5--4--
EP2510125A4 (en) HYPER PRIMER
AU4926P (en) Bonscalib Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
AU4240P (en) Tuckerbox xTriticosecale
EG26256A (en) Oxygen hookah
GB0901126D0 (en) Eco-frame
GB0900696D0 (en) Waxpod
GB0900671D0 (en) Tugbug
GB0900395D0 (en) Kelpipe
GB0900367D0 (en) Shelta
GB0900362D0 (en) Hipestone
GB0900672D0 (en) Clip-m
GB0900285D0 (en) Hangermate
GB0900212D0 (en) Shelta

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231208